Xphyto Therapeutics (CSE: XPHY) VP European Corporate Development and Managing Director at Bunker, Robert Barth joined Steve Darling on Skype from Germany with news the company has signed an agreement with the University of Munich and their Department of Bio-Chemistry.
Barth talks about what research they will do together and also when their facility “The Bunker” will be up and running.
Add related topics to MyProactive
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HERE